MDA Highlights Community Impact as Rare Disease Research Lags

Event summary

  • The Muscular Dystrophy Association (MDA) is spotlighting community stories to mark Rare Disease Day on February 28, 2026.
  • MDA estimates that 7,000 to 10,000 rare diseases affect 25 to 30 million people in the United States, most lacking effective treatments.
  • MDA has operated for 75 years, funding research, providing care through MDA Care Centers, and advocating for individuals with neuromuscular diseases.
  • MDA’s programs include the Resource Center and Gene Therapy Support Network, offering guidance on diagnosis, clinical trials, and caregiving.

The big picture

The MDA’s focus on community stories underscores a persistent challenge in the rare disease space: the lack of effective treatments and the fragmented nature of care. While patient advocacy groups play a vital role, the sheer number of rare diseases (7,000-10,000) and the limited resources available for research and development create a significant hurdle. MDA’s 75-year history demonstrates a commitment to bridging this gap, but sustained progress requires a coordinated effort involving researchers, clinicians, policymakers, and patient communities.

What we're watching

Funding Sustainability
MDA’s reliance on donations and grants makes its long-term operational stability contingent on continued fundraising success, particularly given the broad scope of diseases it supports.
Research Translation
The stories highlight the need for research to translate into tangible therapies; MDA’s ability to influence clinical trial participation and outcomes will be a key indicator of its impact.
Advocacy Effectiveness
The organization’s advocacy efforts will need to demonstrate a clear impact on policy and resource allocation to address the systemic challenges faced by individuals with rare neuromuscular diseases.